Antiretroviral naive and treated patients: Discrepancies of B cell subsets during the natural course of human immunodeficiency virus type 1 infection

Table 1 Patients’ characteristics at enrollment

	HAART naïve patients (n = 41)	Treated patients (n = 41)	P value
Age (yr)	31.76 ± 7.16	34.15 ± 6.17	0.168
Gender (male/female), n (%)	41 (100.0)/0 (0.0)	36 (87.8)/ 4 (12.2)	0.065
Years on HIV infection	3.27 ± 2.78	3.6 = 98 ± 4.41	0.415
Nadir CD4 cell count	573.6 ± 223.4	326 ± 187.3	0.0005
ART duration in months	NA	34.4 ± 14.18	NA
HCV infection, n (%)	2 (4.8)	3 (7.3)	0.345
HBV infection, n (%)	6 (14.6)	4 (9.7)	0.167

All quantitative data are presented as mean ± SD, median (IQR). HAART: Highly active antiretroviral therapy; VL: HIV RNA viral load; HIV: Human immunodeficiency virus; ART: Antiretroviral therapy; NA: Not applicable; HCV: Hepatitis C virus; HBV: Hepatitis B virus.